申请人:ANAXIS PHARMA PTY LTD
公开号:WO2021253098A1
公开(公告)日:2021-12-23
This invention relates to compounds of formula (I) and salts, solvates, tautomers, N-oxides, stereoisomers, polymorphs and/or prodrugs thereof. Also disclosed is the use of the compound of formula (I) to treat necroptosis and/or inhibit RIP1 and/or MLKL.